Deshpande, D., Srivastava, S., Meek, C., Leff, R., & Gumbo, T. (2010). Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium avium. American Society for Microbiology (ASM).
Styl ChicagoDeshpande, Devyani, Shashikant Srivastava, Claudia Meek, Richard Leff, a Tawanda Gumbo. Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification By Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium Avium. American Society for Microbiology (ASM), 2010.
Citace podle MLADeshpande, Devyani, et al. Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification By Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium Avium. American Society for Microbiology (ASM), 2010.